Novel therapeutic approaches in achondroplasia - TV3 Fundació La Marató. Proyecto de la Dra. Mª Ángela Nieto en el que colabora Mª Jesus Vicent y otros IPs del CIPF
Datos básicos
- Código Financiador:
- Año inicial:
- 2020
- Año final:
- 2023
Documentos
- No hay documentos
Participantes
Grupos de Investigación
Financiadores
Resultados del Proyecto
A High-Throughput Chemical Screen in DJ-1 beta Mutant Flies Identifies Zaprinast as a Potential Parkinson's Disease Treatment
Sanz, FJ; (...); Paricio, N
Article. 10.1007/s13311-021-01134-2. 2021
A Hyaluronic Acid Demilune Scaffold and Polypyrrole-Coated Fibers Carrying Embedded Human Neural Precursor Cells and Curcumin for Surface Capping of Spinal Cord Injuries
Elkhenany, H; (...); Manzano, VM
Article. 10.3390/biomedicines9121928. 2021
A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models.
Andreu Z; (...); Vicent MJ
Article. 10.7150/ntno.73606. 2023
A rationally designed self-immolative linker enhances the synergism between a polymer-rock inhibitor conjugate and neural progenitor cells in the treatment of spinal cord injury.
Giraldo E; (...); Moreno-Manzano V
Article. 10.1016/j.biomaterials.2021.121052. 2021
A targeted polypeptide-based nanoconjugate as a nanotherapeutic for alcohol-induced neuroinflammation.
Cuesta, Carlos Manuel; (...); Guerri, Consuelo
Article. 10.1016/j.nano.2021.102376. 2021
Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery
Silvestri, A; (...); Fecke, W
Review. 10.1016/j.drudis.2021.02.024. 2021
Clinically-relevant and predictive cancer models for nanomedicine evaluation
Satchi-Fainaro, R, Florindo, HF, Vicent, MJ
Editorial Material. 10.1016/j.addr.2022.114140. 2022
Current hurdles to the translation of nanomedicines from bench to the clinic
Dordevic, S; (...); Vicent, MJ
Review. 10.1007/s13346-021-01024-2. 2022
DEPLETION OF CD206(HIGH) TUMOUR-ASSOCIATED MACROPHAGES USING A NANOCONJUGATE LIMITS TUMOUR BURDEN & DISSEMINATION IN METASTATIC TRIPLE NEGATIVE BREAST CANCER IN MICE
Lepland, A; (...); Scodeller, P
Meeting Abstract. 10.1136/jitc-2021-ITOC8.11. 2021
Higher-order interfiber interactions in the self-assembly of benzene-1,3,5-tricarboxamide-based peptides in water
Zagorodko, O; (...); Vicent, MJ
Article. 10.1039/d1py00304f. 2021
Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment
Bonilla, P; (...); Moreno-Manzano, V
Article. 10.3390/ijms22115966. 2021
Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases
Soriano-Teruel, PM; (...); Orzaez, M
Article. 10.1038/s41419-021-04420-1. 2021
In Vivo Antitumor and Antimetastatic Efficacy of a Polyacetal-Based Paclitaxel Conjugate for Prostate Cancer Therapy
Fernandez, Y; (...); Vicent, MJ
Article. 10.1002/adhm.202101544. 2022
Lipid-Polyglutamate Nanoparticle Vaccine Platform
Van Lysebetten, D; (...); De Geest, BG
Article. 10.1021/acsami.0c20607. 2021
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
Nanomedicine for the Treatment of Advanced Prostate Cancer
Vicente-Ruiz, S; (...); Vicent, MJ
Review. 10.1002/adtp.202000136. 2021
Polyglutamic acid-based crosslinked doxorubicin nanogels as an anti-metastatic treatment for triple negative breast cancer
Duro-Castano, A; (...); Vicent, MJ
Article. 10.1016/j.jconrel.2021.02.005. 2021
Polymer Conjugation of Docosahexaenoic Acid Potentiates Cardioprotective Therapy in Preclinical Models of Myocardial Ischemia/Reperfusion Injury
Tejedor, S; (...); Vicent, MJ
Article. 10.1002/adhm.202002121. 2021
Polymer-based non-viral vectors for gene therapy in the skin
Tortajada, L, Felip-Leon, C, Vicent, MJ
Review. 10.1039/d1py01485d. 2022
Polypeptides as building blocks for image-guided nanotherapies
Conejos-Sanchez, I; (...); Vicent, MJ
Article. 10.1016/j.cobme.2021.100323. 2021
Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment.
Melnyk T; (...); Vicent MJ
Article. 10.1016/j.jconrel.2023.01.079. 2023
Renal Nano-drug delivery for acute kidney Injury: Current status and future perspectives
Geo, HN; (...); Kiew, LV
Review. 10.1016/j.jconrel.2022.01.033. 2022
Synthetic polypeptides for drug and gene delivery, and tissue engineering.
Yin L; (...); Vicent MJ
Editorial Material. 10.1016/j.addr.2021.113995. 2021
Targeting Alzheimer's disease with multimodal polypeptide-based nanoconjugates
Duro-Castano, A; (...); Vicent, MJ
Article. 10.1126/sciadv.abf9180. 2021
Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide
Lepland, A; (...); Scodeller, P
Article. 10.1021/acs.molpharmaceut.0c00226. 2020
The past, present, and future of breast cancer models for nanomedicine development
Boix-Montesinos, P; (...); Vicent, MJ
Review. 10.1016/j.addr.2021.03.018. 2021
Therapeutic potential of polypeptide-based conjugates: Rational design and analytical tools that can boost clinical translation.
Melnyk T; (...); Vicent MJ
Article. 10.1016/j.addr.2020.10.007. 2020
Transplantation of Human-Fetal-Spinal-Cord-Derived NPCs Primed with a Polyglutamate-Conjugated Rho/Rock Inhibitor in Acute Spinal Cord Injury.
Giraldo E; (...); Moreno Manzano V
Article. 10.3390/cells11203304. 2022
Two-Component Peptidic Molecular Gels for Topical Drug Delivery of Naproxen
Marti-Centelles, R; (...); Escuder, B
Article. 10.1021/acsabm.0c01422. 2021